There is just no headway, a complete sideways trading range since the secondary offering, and nothing money wise seems to break it out. The additional BARDA contract just put this company well over 300 million in spending capital on it's books and that didnt even make it flinch... lol
Yesterday J&J deal for another RSV developer didnt even kick this thing. Of course the broad market itself isnt helping either. Maybe the Q3 report will kick it off once everyone see what is on the books and where we stand in trials going into Q4.
News 
Market Data 
Discover 
